111 Capital Acquires Shares of 7,471 Maximus, Inc. $MMS

Key Points

• 111 Capital acquired 7,471 shares of Maximus, Inc. during the second quarter, valued at approximately $524,000, contributing to the 97.21% of the stock currently owned by institutional investors.
• Maximus reported $2.16 EPS for the latest quarter, exceeding analysts' estimates of $1.39 per share, and raised its FY 2025 guidance to between 7.350-7.550 EPS.
• Analyst ratings for Maximus vary, with one strong buy, one buy, and a hold rating, leading to a consensus target price of $90.00.

111 Capital bought a new stake in Maximus, Inc. (NYSE:MMS - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 7,471 shares of the health services provider's stock, valued at approximately $524,000.

Several other hedge funds also recently added to or reduced their stakes in MMS. AQR Capital Management LLC grew its stake in shares of Maximus by 177.2% during the first quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider's stock valued at $79,341,000 after buying an additional 750,031 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its position in shares of Maximus by 40.0% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider's stock worth $117,921,000 after purchasing an additional 494,372 shares during the last quarter. Boston Partners purchased a new stake in shares of Maximus during the first quarter valued at $20,983,000. Dimensional Fund Advisors LP grew its holdings in shares of Maximus by 20.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider's stock worth $115,620,000 after purchasing an additional 288,990 shares during the last quarter. Finally, Nuveen LLC purchased a new position in Maximus in the 1st quarter worth about $18,586,000. 97.21% of the stock is currently owned by institutional investors.

Maximus Stock Performance

Shares of NYSE:MMS opened at $91.25 on Monday. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $5.14 billion, a price-to-earnings ratio of 16.80 and a beta of 0.57. The firm has a 50 day moving average of $85.06 and a 200 day moving average of $75.44. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.73.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm's revenue was up 2.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, sell-side analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

MMS has been the subject of several research reports. Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 26th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Maximus in a report on Saturday, September 27th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Maximus currently has a consensus rating of "Buy" and a consensus target price of $90.00.

Insider Buying and Selling

In other Maximus news, insider Michelle F. Link sold 1,610 shares of the firm's stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the sale, the insider directly owned 13,508 shares in the company, valued at $1,227,336.88. This trade represents a 10.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is owned by insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.